Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery

被引:113
|
作者
Moghaddam, Seyyed Pouya Hadipour [1 ,2 ]
Yazdimamaghani, Mostafa [1 ,2 ]
Ghandehari, Hamidreza [1 ,2 ,3 ]
机构
[1] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA
[2] Univ Utah, Nano Inst Utah, Utah Ctr Nanomed, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA
关键词
Tunable; Structural difference; Hollow mesoporous silica nanoparticles; GSH-sensitive; Degradable; High loading capacity; BRIDGED SILSESQUIOXANE NANOPARTICLES; LYSOSOMAL THIOL REDUCTASE; IN-VITRO; ORGANOSILICA NANOPARTICLES; THERAPY; CELLS; VIVO; PLATFORM; PATHWAY; AGENTS;
D O I
10.1016/j.jconrel.2018.04.032
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Tunable glutathione (GSH)-sensitive hollow mesoporous silica nanoparticles (HMSiO2 NPs) were developed using a structural difference-based selective etching strategy. These organosilica hollow nanoparticles contained disulfide linkages (S-S) in the outer shell which were degraded by GSH. The particles were compared with their nonGSH-sensitive tetraethyl orthosilicate (TEOS) HMSiO2 counterparts in terms of their synthesis method, characterization, doxorubicin (DOX) release profile, and in vitro cytotoxicity in MCF-7 breast cancer cells. Transmission electron microscopy (TEM) of the particles indicated that the fabricated HMSiO2 NPs had an average diameter of 130 +/- 5 nm. Thermogravimetric analysis (TGA) revealed that GSH-sensitive particles had approximately 5.3% more weight loss than TEOS HMSiO2 NPs. Zeta potential of these redox-responsive particles was -23 +/- 1 mV at pH 6 in deionized (DI) water. Nitrogen adsorption-desorption isotherm revealed that the surface area of the hollow mesoporous nanoreservoirs was roughly 446 +/- 6 m(2) g(-1) and the average diameter of the pores was 2.3 +/- 0.5 nm. TEM images suggest that the nanoparticles started to lose mass integrity from Day 1. The particles showed a high loading capacity for DOX (8.9 +/- 0.5%) as a model drug, due to the large voids existing in the hollow structures. Approximately 58% of the incorporated DOX released within 14 days in phosphate buffered saline (PBS) at pH 6 and in the presence of 10mM of GSH, mimicking intracellular tumor microenvironment while release from TEOS HMSiO2 NPs was only c.a. 18%. The uptake of these hollow nanospheres by MCF-7 cells and RAW 264.7 macrophages was evaluated using TEM and confocal microscopy. The nanospheres were shown to accumulate in the endolysosomal compartments after incubation for 24 h with the maximum uptake of c.a. 2.1 +/- 0.3% and 5.2 +/- 0.4%, respectively. Cytotoxicity of the nanospheres was investigated using CCK-8 assay. Results indicate that intact hollow particles (both GSH-sensitive and TEOS HMSiO2 NPs) were nontoxic to MCF-7 cells after incubation for 24 h within the concentration range of 0-1000 mu g ml(-1). DOX-loaded GSH-sensitive nanospheres containing 6 mu g ml(-1) of DOX killed c.a. 51% of MCF-7 cells after 24 h while TEOS HMSiO2 NPs killed c. a. 20% with the difference being statistically significant. Finally, cytotoxicity data in RAW 264.7 macrophages and NIH 3T3 fibroblasts shows that intact GSH-sensitive HMSiO2 NPs did not show any toxic effects on these cells with the concentrations equal or < 125 mu g ml(-1).
引用
收藏
页码:62 / 75
页数:14
相关论文
共 50 条
  • [31] Mesoporous silica nanoparticles as vehicles for drug delivery
    Adristya, I. M.
    Suryaningtyas, A. D.
    Wijaya, J.
    Pangestu, F. C.
    Hartono, S. B.
    Soewignyo, L. H.
    Irawaty, W.
    26TH REGIONAL SYMPOSIUM ON CHEMICAL ENGINEERING (RSCE 2019), 2020, 778
  • [32] Mesoporous silica nanoparticles for drug and gene delivery
    Yixian Zhou
    Guilan Quan
    Qiaoli Wu
    Xiaoxu Zhang
    Boyi Niua
    Biyuan Wu
    Ying Huang
    Xin Pan
    Chuanbin Wu
    ActaPharmaceuticaSinicaB, 2018, 8 (02) : 165 - 177
  • [33] Mesoporous silica nanoparticles for pulmonary drug delivery
    Garcia-Fernandez, Alba
    Sancenon, Felix
    Martinez-Manez, Ramon
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 177
  • [34] Mesoporous silica nanoparticles as a drug delivery mechanism
    Zhang, Wei
    Liu, Hongwei
    Qiu, Xilong
    Zuo, Fanjiao
    Wang, Boyao
    OPEN LIFE SCIENCES, 2024, 19 (01):
  • [35] Hydrotalcite-gated hollow mesoporous silica delivery system for controlled drug release
    Jin, Li
    Huang, Qing-Jun
    Zeng, Hong-Yan
    Du, Jin-Ze
    Xu, Sheng
    Chen, Chao-Rong
    MICROPOROUS AND MESOPOROUS MATERIALS, 2019, 274 : 304 - 312
  • [36] The viability of mesoporous silica nanoparticles for drug delivery
    Zhang, Jixi
    Rosenholm, Jessica M.
    THERAPEUTIC DELIVERY, 2015, 6 (08) : 891 - 893
  • [37] Ingenious pH-sensitive dextran/mesoporous silica nanoparticles based drug delivery systems for controlled intracellular drug release
    Zhang, Min
    Liu, Jia
    Kuang, Ying
    Li, Qilin
    Zheng, Di-Wei
    Song, Qiongfang
    Chen, Hui
    Chen, Xueqin
    Xu, Yanglin
    Li, Cao
    Jiang, Bingbing
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2017, 98 : 691 - 700
  • [38] New Progress in the Applications of Mesoporous Silica Nanoparticles to Controlled Drug Delivery System
    Yuan, Li
    Wang, Beidi
    Tang, Qianqian
    Zhang, Xiaohong
    Zhang, Xiaohuan
    Yang, Dong
    Hu, Jianhua
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2010, 30 (05) : 640 - 647
  • [39] Multifunctional Mesoporous Silica Nanoparticles for Cancer-Targeted and Controlled Drug Delivery
    Zhang, Quan
    Liu, Fang
    Kim Truc Nguyen
    Ma, Xing
    Wang, Xiaojun
    Xing, Bengang
    Zhao, Yanli
    ADVANCED FUNCTIONAL MATERIALS, 2012, 22 (24) : 5144 - 5156
  • [40] Functional Mesoporous Silica Nanoparticles for Photothermal-Controlled Drug Delivery In Vivo
    Yan, Hong
    Teh, Cathleen
    Sreejith, Sivaramapanicker
    Zhu, Liangliang
    Kwok, Anna
    Fang, Weiqin
    Ma, Xing
    Kim Truc Nguyen
    Korzh, Vladimir
    Zhao, Yanli
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (33) : 8373 - 8377